Similar Articles
991 Layered enhancement at magnetic resonance enterography in inflammatory bowel disease: A meta-analysis
992 Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness
993 Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis
994 Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we
995 Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
996 Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
997 Performance of common imaging techniques vs serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis
998 Left colonic metastasis from primary hepatocellular carcinoma: A case report
999 Effect of dl-3-n-butylphthalide on infarction volume in animal models of ischemic stroke: A meta-analysis
1000 Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA